Monsanto (MON) Releases Quarterly Earnings Results, Misses Estimates By $0.01 EPS

Monsanto (NYSE:MON) announced its earnings results on Thursday. The basic materials company reported $0.41 earnings per share for the quarter, missing analysts’ consensus estimates of $0.42 by ($0.01), Briefing.com reports. Monsanto had a return on equity of 42.40% and a net margin of 15.44%. The firm had revenue of $2.66 billion for the quarter, compared to the consensus estimate of $2.77 billion. During the same period in the prior year, the business earned $0.21 EPS. Monsanto’s quarterly revenue was up .3% on a year-over-year basis.

Monsanto (MON) opened at $118.00 on Thursday. Monsanto has a twelve month low of $104.83 and a twelve month high of $122.79. The firm has a market cap of $51,940.00, a PE ratio of 23.23, a P/E/G ratio of 1.69 and a beta of 1.04. The company has a current ratio of 1.35, a quick ratio of 0.83 and a debt-to-equity ratio of 1.12.

The company also recently declared a quarterly dividend, which will be paid on Friday, January 26th. Investors of record on Friday, January 5th will be issued a dividend of $0.54 per share. This represents a $2.16 annualized dividend and a yield of 1.83%. The ex-dividend date is Thursday, January 4th. Monsanto’s dividend payout ratio (DPR) is presently 42.52%.

In related news, CFO Pierre Courduroux sold 4,320 shares of the business’s stock in a transaction dated Thursday, October 19th. The shares were sold at an average price of $122.00, for a total transaction of $527,040.00. Following the transaction, the chief financial officer now directly owns 48,388 shares in the company, valued at $5,903,336. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Steven Mizell sold 11,526 shares of the business’s stock in a transaction dated Monday, October 9th. The stock was sold at an average price of $119.70, for a total transaction of $1,379,662.20. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 23,736 shares of company stock worth $2,871,255. 0.79% of the stock is owned by corporate insiders.

A number of equities analysts recently weighed in on MON shares. BMO Capital Markets reissued a “buy” rating and set a $128.00 target price on shares of Monsanto in a research note on Thursday, October 5th. Zacks Investment Research raised shares of Monsanto from a “hold” rating to a “buy” rating and set a $132.00 target price for the company in a research note on Thursday, September 14th. Barclays reissued an “equal weight” rating and set a $124.00 target price (up previously from $120.00) on shares of Monsanto in a research note on Thursday, October 5th. Jefferies Group reissued a “hold” rating and set a $128.00 target price on shares of Monsanto in a research note on Friday, September 15th. Finally, Royal Bank of Canada reissued a “hold” rating and set a $128.00 target price on shares of Monsanto in a research note on Wednesday, November 15th. Twelve investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. The stock currently has a consensus rating of “Hold” and an average target price of $124.61.

TRADEMARK VIOLATION WARNING: This report was published by American Banking News and is owned by of American Banking News. If you are reading this report on another site, it was illegally stolen and republished in violation of US & international copyright & trademark law. The correct version of this report can be viewed at https://www.americanbankingnews.com/2018/01/04/monsanto-mon-posts-quarterly-earnings-results-meets-estimates.html.

About Monsanto

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Earnings History for Monsanto (NYSE:MON)

Receive News & Ratings for Monsanto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply